Document 0245 DOCN M9590245 TI Longstanding psoriasis: a remission in a patient with AIDS and a falling T cell count. DT 9509 AU Hammett RJ; Edwards R; HIV Medicine Unit, Royal North Shore Hospital, University of; Sydney, St. Leonards N.S.W. SO Annu Conf Australas Soc HIV Med. 1994 Nov 3-6;6:279 (unnumbered poster). Unique Identifier : AIDSLINE ASHM6/95291854 AB The development of psoriasis in patients with HIV/AIDS has been well described. In most reported cases there has been a deterioration in the patient's psoriasis with any decrease in CD4 count. Psoriasis in this setting is often resistant to conventional forms of therapy, although there have been reports of treatment success with PUVA therapy, and Vitamin D analogues. HIV itself can be identified within CD4 positive, Factor XIIIa dermal dendrocytes in patients with psoriasis; although the role it plays in the pathogenesis of the condition is uncertain. We present the case of a 59 year old HIV positive patient who had had widespread psoriasis for most of his adult life. The psoriasis involved the skin on the extensor aspects of the patient's elbows and knees, the abdomen and scalp. There was also evidence of pitting, ridging, and onycholysis of nails on both hands. He was diagnosed with HIV infection in May 1992, after presenting with a three month history of cough, dyspnoea and fever which was found to be due to Pneumocystis pneumonia. His CD4 count at the time of diagnosis was 243 x 1000 per cubic millimetre. At that time he had been receiving PUVA and topical treatment for his psoriasis. He was commenced on zidovudine, acyclovir, trimethoprim-sulphamethoxazole and nystatin. By April 1993 his CD4 count had fallen to 46 x 1000/cubic mm. Didanosine was started. He noted at this time that his psoriasis had improved markedly despite ceasing all treatment for it. He remained well until December 1993 when he developed septicaemia secondary to Mycobacterium Avium Intracellulare, and Staph. epidermidis. He was commenced on Rifampicin, Chlarithromycin, Ethambutol and Flucloxacillin, and recovered from this illness. At follow up in May 1994 he remained relatively well; in particular his psoriasis had disappeared completely from his skin, with just three fingernails on one hand exhibiting some residual pitting. Similar improvements in disease activity have been noted in patients with Rheumatoid arthritis and Systemic lupus erythematosis, suggesting a role for CD4 cells in the pathogenesis of all of these conditions. DE Acquired Immunodeficiency Syndrome/*IMMUNOLOGY AIDS-Related Opportunistic Infections/IMMUNOLOGY Case Report CD4 Lymphocyte Count Human Male Middle Age Psoriasis/*IMMUNOLOGY Remission, Spontaneous *T-Lymphocytes/IMMUNOLOGY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).